DSS.AMEXDss, INC

DEFR14A: DSS Amends Proxy, Sets 2025 Annual Meeting Agenda

Sentiment:

Definitive Proxy Statement Amendment


๐Ÿ“‹All filings for Dss, INC

DSS, Inc. filed an amendment to its definitive proxy statement, confirming the agenda for its 2025 Annual Meeting of Stockholders on December 3, 2025, which includes director elections, auditor ratification, and an advisory vote on executive compensation.

Delay expectedThe original Proxy Statement filed on October 20, 2025, inadvertently omitted the form of proxy card, necessitating this amendment.A promissory note with VEII, Inc. (Note 10) for $1,000,000, originally due July 26, 2024, was amended to extend its maturity date to July 26, 2025.Loan agreements with BMI Capital, Inc. (BMIC Loan) and Lee Wilson Tsz Kin (Wilson Loan), both originally maturing on October 12, 2022, included auto-renewal periods, effectively extending their repayment timelines.
Capital raiseOn December 10, 2024, DSS entered into a private placement agreement with Alset Inc., a related party, to sell 820,597 shares of common stock for approximately $803,000.On December 10, 2024, DSS entered into a private placement agreement with Heng Fai Ambrose Chan, the Chairman of the Board and a related party, to sell 205,149 shares of common stock for approximately $197,000.

Summary

  • An Amendment No. 1 to Schedule 14A was filed to include the form of proxy card that was inadvertently omitted from the original Proxy Statement filed on October 20, 2025.
  • The 2025 Annual Meeting of Stockholders will be held on Wednesday, December 3, 2025, at 9:00 a.m. Eastern time.
  • The agenda for the Annual Meeting includes the election of 7 director nominees, the ratification of HTL International, LLC. as the independent registered public accounting firm for fiscal year ending December 31, 2025, and an advisory vote on executive compensation.
  • The record date for stockholders entitled to vote at the Annual Meeting was fixed as the close of business on October 6, 2025, with 9,092,518 shares of common stock outstanding.
  • The Board of Directors recommends a vote FOR all proposals, including the election of all director nominees, the ratification of HTL International, LLC., and the approval of executive compensation.
  • Jason Grady was elected Interim Chief Executive Officer effective August 23, 2024, following Frank D. Heuszel's resignation to lead a subsidiary.
  • Significant related party transactions were disclosed, including investments, promissory notes, and recent private placements of common stock to related entities and the Chairman, Ambrose Chan Heng Fai.

Sentiment

Score: 5

Explanation: The filing is largely procedural, focusing on an amendment to a proxy statement and outlining routine annual meeting proposals. While it discloses concerning related party transactions, including fully reserved notes and unrealized investment losses, it also highlights standard corporate governance practices. The interim nature of key executive roles introduces some uncertainty, but the capital raises from related parties provide funding. Overall, the information is mixed, preventing a strong positive or negative sentiment.

Positives

  • The company is proceeding with its annual meeting, demonstrating adherence to corporate governance schedules.
  • The Board of Directors has separated the roles of Chief Executive Officer and Chairman, which can enhance corporate oversight and strategic focus.
  • The Audit Committee confirmed that the previous auditor's report for the fiscal year ended December 31, 2024, contained no adverse opinion, disclaimer, qualification, or modification.
  • The company maintains a Code of Ethics and structured committees (Audit, Compensation, Nominating & Corporate Governance) to oversee key areas of governance and risk.

Negatives

  • Several promissory notes from related parties, including BMI Capital, Inc. and VEII, Inc., have significant outstanding balances, with some fully reserved for as of December 31, 2024, indicating potential credit risk or impairment.
  • An investment in Alset International Limited, a related party, resulted in unrealized losses of approximately $750,000 in 2024 and $50,000 in 2023.
  • Key executive roles, including Interim Chief Executive Officer (Jason Grady) and Chief Financial Officer (Todd D. Macko), are currently under month-to-month interim agreements, suggesting a lack of long-term contractual stability in leadership.
  • The filing itself was an amendment due to the inadvertent omission of the proxy card, indicating a procedural oversight.

Risks

  • The reliance on interim employment agreements for the Chief Executive Officer and Chief Financial Officer introduces uncertainty regarding long-term leadership stability and succession planning.
  • Extensive related party transactions, including significant beneficial ownership by the Chairman and loans to/from related entities, pose potential conflicts of interest and may not always be on arm's-length terms.
  • The full reservation of certain notes receivable from related parties highlights credit risk and potential financial losses from these dealings.
  • Unrealized losses on the investment in Alset International Limited indicate market volatility and potential impairment risks associated with related party investments.

Future Outlook

The Compensation and Management Resources Committee will consider the outcome of the non-binding advisory vote on executive compensation when evaluating future executive compensation arrangements. The company will continue to file periodic reports and other information with the SEC.

Management Comments

  • "The Board of Directors recommends that you vote FOR the proposals set forth in this Notice of Annual Meeting of Stockholders and the Proxy Statement."
  • "We believe that our compensation policies for the Named Executive Officers are designed to attract, motivate and retain talented executive officers and are aligned with the long-term interests of the Companys stockholders."
  • "The Board does not believe that our compensation program encourages excessive or inappropriate risk-taking."

Industry Context

This filing is a routine definitive proxy statement amendment, common across all publicly traded companies, detailing proposals for an upcoming annual meeting and executive compensation. The company's diversified business interests, spanning packaging, real estate, and digital transformation, make direct industry comparisons challenging without more specific operational details. The prevalence of related party transactions is a company-specific characteristic rather than a broad industry trend.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerFrank D. HeuszelJason Grady (Interim)August 23, 2024Mr. Heuszel stepped down to become Chief Executive Officer of Impact BioMedical, Inc., a subsidiary of DSS. Mr. Grady was elected Interim CEO.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Leadership StructureThe positions of Chief Executive Officer and Chairman of the Board are held by two different individuals (Jason Grady as Interim CEO and Ambrose Chan Heng Fai as Chairman).August 23, 2024This separation allows the Chief Executive Officer to focus on daily business strategies and the Board Chairman to concentrate on the long-term strategic direction of the company, potentially enhancing oversight and operational focus.

Legal Proceedings

  • None of the directors or executive officers have been involved in any legal proceedings in the past 10 years that would require disclosure under Item 401(f) of Regulation S-K.

Related Party Transactions

  • DSS owns approximately 4% of Alset International Limited, where Ambrose Chan (DSS Chairman and largest shareholder) is Executive Director and CEO. DSS recorded unrealized losses of $750,000 in 2024 and $50,000 in 2023 on this investment.
  • DSS Financial Management Inc. entered into two promissory notes (Note 8 for $100,000 and Note 9 for $102,000) with BMI Capital, Inc. (BMIC), a related party where DSS owns 24.9%. Both notes had outstanding principal and interest fully reserved for as of December 31, 2024.
  • APF and VEII, Inc. (where Ambrose Chan is on the board) entered a $1,000,000 promissory note (Note 10) with an amended due date of July 26, 2025. Approximately $480,000 of this note was reserved as of March 31, 2024.
  • LVAM entered a $3,000,000 loan agreement with BMIC (related party) and another $3,000,000 loan agreement with Lee Wilson Tsz Kin (related party), both with auto-renewal periods.
  • On December 10, 2024, DSS sold 820,597 common shares for approximately $803,000 to Alset Inc., a related party, in a private placement.
  • On December 10, 2024, DSS sold 205,149 common shares for approximately $197,000 to Heng Fai Ambrose Chan, the Chairman of the Board and a related party, in a private placement.
  • On February 6, 2025, Heng Fai Holdings Limited (beneficially owned by Ambrose Chan) was awarded 1,000,000 shares of DSS common stock as bonus compensation for services rendered.
  • Ambrose Chan Heng Fai receives $120,000 annually from a consulting agreement with DSS.
  • Lim Sheng Hon Danny receives $50,000 annually from a consulting agreement with DSS.

Stakeholder Impact

  • **Shareholders**: Will participate in the annual meeting to vote on key governance matters. The significant beneficial ownership by the Chairman and related entities (66.2%) means their votes will largely determine the outcome of proposals. The extensive related party transactions, including share issuances and notes receivable/payable, directly impact shareholder value and the company's financial health.
  • **Employees**: Executive compensation and equity incentive plans are detailed. The interim nature of the CEO and CFO roles could introduce uncertainty regarding long-term strategic direction and stability.
  • **Creditors**: The disclosure of notes receivable from related parties, some of which are fully reserved, and loans from related parties, indicates a complex financial structure that creditors would need to evaluate for potential credit risks.

Next Steps

  • Hold the 2025 Annual Meeting of Stockholders on December 3, 2025.
  • Elect 7 director nominees to the Board of Directors.
  • Ratify the appointment of HTL International, LLC. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
  • Conduct an advisory vote on executive compensation.
  • The Compensation and Management Resources Committee will consider the outcome of the stockholder vote on executive compensation when determining future arrangements.

Key Dates

DateDescription
January 1, 2020Start of the period for related party transactions disclosure.
October 13, 2021LVAM entered into loan agreements with BMI Capital, Inc. (BMIC) and Lee Wilson Tsz Kin.
March 1, 2022DSS, Inc. completed the True Partner Transaction.
March 2022The Wilson Loan was funded.
April 15, 2022Schedule 14A Proxy Statement filed regarding the True Partner Transaction.
May 17, 2022Stockholders approved the issuance of the True Partner Transaction Shares.
May 18, 2022Form 8-K filed regarding stockholder approval of True Partner Transaction Shares.
July 7, 2022Company issued 878,547 shares to Alset EHome International Inc. (now Alset, Inc.).
July 22, 2022Mr. William Wu Wai Leung was appointed Lead Independent Director.
July 26, 2022APF and VEII, Inc. entered into a promissory note (Note 10).
August 29, 2022DSS Financial Management Inc and BMI Capital, Inc. entered into a promissory note (Note 8).
May 8, 2023DSS Financial Management Inc and BMI Capital, Inc. entered into a promissory note (Note 9).
December 12, 2023Frank D. Heuszel and DSS, Inc. executed a letter agreement for interim CEO services.
December 15, 2023Jason Grady and DSS, Inc. executed a letter agreement for interim COO services.
December 15, 2023Todd Macko and DSS, Inc. executed a letter agreement for interim CFO services.
December 31, 2023Fiscal year end for executive compensation and certain financial metrics.
March 31, 2024Date as of which approximately $480,000 of the VEII Note 10 was reserved.
June 2024Frank D. Heuszel's consulting agreement with APB was terminated.
August 23, 2024Frank D. Heuszel stepped down as CEO of DSS; Jason Grady was elected Interim CEO.
September 30, 2024Date for outstanding principal and interest approximation for VEII Note 10.
October 2024Jason Grady was named Interim CEO of DSS.
December 10, 2024DSS entered into securities purchase agreements with Alset Inc. and Ambrose Chan for private placements.
December 31, 2024Fiscal year end for executive compensation and certain financial metrics.
January 31, 2025Board of Directors approved the bonus share award to Heng Fai Holdings Limited.
February 6, 2025Heng Fai Holdings Limited was awarded 1,000,000 shares of common stock.
June 27, 2025Deadline for stockholder proposals under Rule 14a-8 for the 2024 annual meeting.
July 26, 2025Amended maturity date for the promissory note with VEII, Inc. (Note 10).
August 29, 2025Maturity date for the promissory note with BMI Capital, Inc. (Note 8).
October 6, 2025Record date for the 2025 Annual Meeting of Stockholders and date for equity compensation plan information and beneficial ownership.
October 20, 2025Original Proxy Statement filed with the SEC.
October 21, 2025Approximate date proxy materials were first provided to stockholders.
December 3, 2025Date of the 2025 Annual Meeting of Stockholders.
December 31, 2025Fiscal year end for the auditor appointment.
May 7, 2026Maturity date for the promissory note with BMI Capital, Inc. (Note 9).

Recommendation

hold

This filing is a routine proxy statement amendment for an annual meeting, primarily addressing procedural and governance matters. It does not contain new operational or financial performance data that would typically drive significant share price movement. While the extensive related party transactions, including fully reserved notes and unrealized investment losses, warrant close monitoring due to potential conflicts of interest and financial risks, they are historical disclosures within a governance document. The interim status of key executive roles also adds a layer of uncertainty. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while closely observing future operational results, financial performance, and the resolution of leadership and related party issues.

Keywords

DSS, SEC filing, Proxy Statement, Annual Meeting, Corporate Governance, Executive Compensation, Director Election, Auditor Ratification, Related Party Transactions, Financial Reporting, Stockholder Vote, NYSE American

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.